Chapters

Transcript

Video

Based on results from North Star as well as other observational trials, what kind of results should clinicians expect when they transition/convert patients from T4 monotherapy to combination therapy with DTE? What percentage of patients can be expected to respond?

Based on results from North Star as well as other observational trials, what kind of results should clinicians expect when they transition/convert patients from T4 monotherapy to combination therapy with DTE? What percentage of patients can be expected to respond?


Created by

CMEducation Resources IQ&A Thyroid Hormone Replacement Medical Intelligence Zone

Presenter

Francesco Saverio Celi, MD, MHSc

Francesco Saverio Celi, MD, MHSc

William G. Blackard Professor of Medicine Chair, Division of Endocrinology Diabetes and Metabolism Department of Internal Medicine Virginia Commonwealth University Director, VCU Health Diabetes Program Richmond, Virginia